UBS lowered the firm’s price target on Colgate-Palmolive (CL) to $92 from $99 and keeps a Buy rating on the shares. The firm sees another “dynamic” earnings season for U.S. consumer staples, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL: